In Reply: Drs Kaneda and Ako raise questions about late loss in our study. The finding that late loss was approximately 0.16 mm less with VBT compared with paclitaxel-eluting stent implantation in the injury zone reflects in part the much greater acute gain (approximately 0.55 mm more) with the drug-eluting stent, which by itself induces more late loss,1 as well as the significantly longer length of the drug-eluting stent injury zone.
Stone GW, Popma JJ, Ellis SG. Paclitaxel-Eluting Stents, Brachytherapy, and In-Stent Restenosis—Reply. JAMA. 2006;296(15):1838–1839. doi:10.1001/jama.296.15.1838-c
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: